Apparently the US Army...
Clorox has been beaten down, but is in position to outperform the market for the remainder of 2013.
Sometimes selling is just smart tax planning.
When looking for investments you may want to look to the S&P 500’s dividend aristocrat list.
Despite it's recent run-up, this company is a disaster longer-term.
The company said today that its Supercharger network is now online in Norway – offering free Model S charging throughout the country.
Learning from the market's past to understand its present.
Tire manufacturing is rife with competition, high expenses and thin margins. Investors need to be careful investing in this sector.
We'll know soon enough if Biodel's BIOD-123 has what it takes.
Breaking down one analyst's figures on the next iBlockbuster.
Furloughs of federal workers add to decline in wages, salaries.
Analyzing the impact of acquisition of Enray by J.M. Smucker.
Visa has pulled back over 9% and is poised to pop.
Windstream's new holding company will trade under the "WIN" ticker symbol on the Nasdaq and current shares will convert to Windstream Holdings shares on a one-for-one basis.
Today's weaker consumer sentiment numbers point to a continuing trend of uncertainty about the future of the U.S. economy.
Talk about turning an industry on its head.
As the medical device industry evolves, what's Medtronic doing to shape its future success?
Northrop, Boeing, BAE, Tetra Tech, and General Electric are among the winners.
A probe from the Food and Drug Administration is never a good thing, but it's not the most worrisome factor for shareholders.
Let's see what the numbers say about Toll Brothers (TOL).